Cargando…

A Preliminary Exploration Using Imaging Methods to Predict the Possibility of the Recurrence of Serous Ovarian Cancer in Patients Undergoing Total Resection

BACKGROUND: The purpose of our research was to explore the value of preoperative CT and MRI examinations and clinical indicators in the prediction of recurrence of ovarian serous carcinoma in patients who underwent satisfactory staging surgery. PROCEDURE: Detailed inclusion and exclusion criteria we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Mengshi, Huang, Shan, Dong, Jiangning, Yan, Hong, Fang, Xin, Zhang, Ping, Cao, Feng, Chen, Yulan, Zhang, Qiujun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072969/ https://www.ncbi.nlm.nih.gov/pubmed/35530348 http://dx.doi.org/10.3389/fonc.2022.754067

Ejemplares similares

A Nomogram Combining MRI Multisequence Radiomics and Clinical Factors for Predicting Recurrence of High-Grade Serous Ovarian Carcinoma
por: Li, Cuiping, et al.
Publicado: (2022)

Nomograms of Combining MRI Multisequences Radiomics and Clinical Factors for Differentiating High-Grade From Low-Grade Serous Ovarian Carcinoma
por: Li, Cuiping, et al.
Publicado: (2022)

MRI-based radiomics and ADC values are related to recurrence of endometrial carcinoma: a preliminary analysis
por: Zhang, Kaiyue, et al.
Publicado: (2021)

Isolated recurrence of ovarian serous adenocarcinoma to adrenal gland
por: Borczuk, Rachel, et al.
Publicado: (2022)

Ovarian serous carcinoma in which mediastinal recurrence of the cancer was resected 16 years after surgery: A case report
por: Miura, Hiroyuki, et al.
Publicado: (2022)

Morphological and molecular basis of ovarian serous carcinoma
por: Rosen, Daniel G, et al.
Publicado: (2010)

Identification of clinical and molecular features of recurrent serous borderline ovarian tumour
por: Lu, Ziyang, et al.
Publicado: (2022)

Nomograms of Combining Apparent Diffusion Coefficient Value and Radiomics for Preoperative Risk Evaluation in Endometrial Carcinoma
por: Zhang, Kaiyue, et al.
Publicado: (2021)

Human cytomegalovirus in high grade serous ovarian cancer possible implications for patients survival
por: Carlson, Joseph W., et al.
Publicado: (2018)

Keratin 5 overexpression is associated with serous ovarian cancer recurrence and chemotherapy resistance
por: Ricciardelli, Carmela, et al.
Publicado: (2017)

The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma
por: Smith, Philip, et al.
Publicado: (2023)

MDCT-Based Radiomics Features for the Differentiation of Serous Borderline Ovarian Tumors and Serous Malignant Ovarian Tumors
por: Yu, Xin-ping, et al.
Publicado: (2021)

LncRNA LIFR‐AS1 overexpression suppressed the progression of serous ovarian carcinoma
por: Liu, Fang, et al.
Publicado: (2022)

Exploring the Control of PARP1 Levels in High-Grade Serous Ovarian Cancer
por: Raspaglio, Giuseppina, et al.
Publicado: (2023)

Pathogenic Heteroplasmic Somatic Mitochondrial DNA Mutation Confers Platinum-Resistance and Recurrence of High-Grade Serous Ovarian Cancer
por: Ni, Jing, et al.
Publicado: (2020)

Expression of Fatty Acid Synthase Depends on NAC1 and Is Associated with Recurrent Ovarian Serous Carcinomas
por: Ueda, Stefanie M., et al.
Publicado: (2010)

SIRT4 and SIRT6 Serve as Novel Prognostic Biomarkers With Competitive Functions in Serous Ovarian Cancer
por: Wang, Huihuan, et al.
Publicado: (2021)

EGF-Induced EMT and Invasiveness in Serous Borderline Ovarian Tumor Cells: A Possible Step in the Transition to Low-Grade Serous Carcinoma Cells?
por: Cheng, Jung-Chien, et al.
Publicado: (2012)

Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas
por: Sadlecki, Pawel, et al.
Publicado: (2018)

Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells
por: Dey, Puja, et al.
Publicado: (2022)

Time to Recurrence and Survival in Serous Ovarian Tumors Predicted from Integrated Genomic Profiles
por: Mankoo, Parminder K., et al.
Publicado: (2011)

Derivation and characterization of matched cell lines from primary and recurrent serous ovarian cancer
por: Létourneau, Isabelle J, et al.
Publicado: (2012)

MODY5 and Serous Ovarian Carcinoma in 17q12 Recurrent Deletion Syndrome
por: Kumar, Aswathi, et al.
Publicado: (2023)

Exploring the Role of Fallopian Ciliated Cells in the Pathogenesis of High-Grade Serous Ovarian Cancer
por: Coan, Michela, et al.
Publicado: (2018)

Differential expression of argininosuccinate synthetase in serous and non‐serous ovarian carcinomas
por: Cheon, Dong‐Joo, et al.
Publicado: (2014)

Evaluating the Utility of ctDNA in Detecting Residual Cancer and Predicting Recurrence in Patients with Serous Ovarian Cancer
por: Zhu, Jie Wei, et al.
Publicado: (2023)

Mutational heterogeneity in non-serous ovarian cancers
por: Teer, Jamie K., et al.
Publicado: (2017)

Rapid Interval Recurrence of Glioblastoma Following Gross Total Resection: A Possible Indication for GammaTileⓇ Brachytherapy
por: Easwaran, Teresa P, et al.
Publicado: (2021)

4D Doppler Ultrasound in High Grade Serous Ovarian Cancer Vascularity Evaluation—Preliminary Study
por: Kudla, Marek Jerzy, et al.
Publicado: (2021)

The Multimodal Ultrasound Features of Ovarian Serous Surface Papillary Borderline Tumor
por: Xie, Lijun, et al.
Publicado: (2022)

ESRRA-C11orf20 Is a Recurrent Gene Fusion in Serous Ovarian Carcinoma
por: Salzman, Julia, et al.
Publicado: (2011)

Characterisation of homologous recombination deficiency in paired primary and recurrent high-grade serous ovarian cancer
por: Patel, Jai N., et al.
Publicado: (2018)

ZNF671 DNA methylation as a molecular predictor for the early recurrence of serous ovarian cancer
por: Mase, Shoko, et al.
Publicado: (2019)

Author Correction: The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma
por: Smith, Philip, et al.
Publicado: (2023)

Chemotherapy is not necessary for early-stage serous and endometrioid ovarian cancer after undergoing comprehensive staging surgery
por: Li, Shuqing, et al.
Publicado: (2020)

Notch signaling in serous ovarian cancer
por: Groeneweg, Jolijn W, et al.
Publicado: (2014)

Gastric metastasis of ovarian serous cystadenocarcinoma
por: Yang, Shiqiang
Publicado: (2018)

Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018)

Integrated Analysis To Identify Molecular Biomarkers Of High-Grade Serous Ovarian Cancer
por: Si, Manfei, et al.
Publicado: (2019)

Development and Validation of an RNA-Binding Protein-Based Prognostic Model for Ovarian Serous Cystadenocarcinoma
por: He, Yunan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_27tk75pnocepuplohidn5nj46b